Published : Mar 2019
Tables : 128
Figures : 38
Category : Medical Devices
No. of Pages : 239
Report Code : LI_18654
"According to a new report published by Allied Market Research, titled,""Digital PCR Market by Technology, Product Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"the global digital PCR market was valued at $318 million in 2017, and is projected to reach $1,206 million by 2025, growing at a CAGR of 18.0% from 2018 to 2025. North America was the highest contributor to the digital PCR market in 2017; however, Asia-Pacific is expected to witness the highest growth during the forecast period. Digital PCR is a simple and reproducible method that does not rely on a calibration curve for sample target quantification. It allows precise, highly sensitive quantification of nucleic acids. It is used for absolute quantification and analysis of minority sequences. This type of PCR enhances the sensitivity of real-time PCR and detects rare events such as single-nucleotide mutations in a population of wild-type sequences. With digital PCR, a sample is partitioned so that individual nucleic acid molecules within the sample are localized and concentrated within many separate regions. After PCR amplification, nucleic acids may be quantified by counting the regions that contain PCR end-product and positive reactions. The major factors that drive the growth of the digital PCR market are a rise in the prevalence of infectious disease, increase in awareness and acceptance of personalized medicines, and technological advancements in the field of digital PCR. However, the high cost of digital PCR devices and reimbursement issues limit the market growth. However, the increase in funding for R&D activities is anticipated to provide numerous opportunities for market growth during the forecast period. Based on technology, the market is bifurcated into droplet digital PCR (ddPCR) and BEAMing digital PCR. The ddPCR segment was the major revenue contributor in2017 and is anticipated to continue this trend during the forecast period, the ddPCR technique provides a precise measure of DNA molecules through each drop. In addition, the massive sample partitioning is a key aspect of the droplet digital PCR technique, which increases the demand. Depending on type, the market is categorized into digital PCR systems, consumables & reagents, and software & services. The software & services segment is projected to experience rapid growth during the forecast period, as the software helps to improve the efficiency of management of digital PCR data and thus, the rise in demand for these products propels the market growth. North America was the leading revenue contributor to the global digital polymerase chain reaction market in 2017 and is expected to remain dominant throughout the forecast period. This is attributed to its well-developed healthcare industry, the presence of leading molecular diagnostics manufacturers in the region, and rise in a number of patients using personalized medicines. However, Asia-Pacific is expected to grow at the highest CAGR of 19.1% during the study period, as it offers lucrative opportunities for the molecular diagnostics players due to increasing in a number of patients suffering from chronic diseases and improvement in healthcare facilities in the region. Key Findings of the Digital PCR Market: Based on application, the forensics segment is projected to grow at the highest rate during the analysis period. North America dominated the global digital PCR market in 2017 and is projected to continue its dominance in the future. China is expected to grow at the highest rate in Asia-Pacific during the forecast period. Based on product type, consumables and reagents was the largest contributor in 2017. Based on technology, the ddPCR segment generated the highest revenue and is expected to continue its dominance in the future. The key players operating in the global digital PCR market include Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Expedeon AG, Fluidigm Corporation, JN Medsys, Merck KGaA, Qiagen N.V. (Formulatrix, Inc.), Stilla Technologies, Sysmex Corporation (Sysmex Inostics GmbH), and Thermo Fisher Scientific, Inc. About Us: Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry."
"According to a new report published by Allied Market Research, titled,""Digital PCR Market by Technology, Product Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"the global digital PCR market was valued at $318 million in 2017, and is projected to reach $1,206 million by 2025, growing at a CAGR of 18.0% from 2018 to 2025. North America was the highest contributor to the digital PCR market in 2017; however, Asia-Pacific is expected to witness the highest growth during the forecast period.
Digital PCR is a simple and reproducible method that does not rely on a calibration curve for sample target quantification. It allows precise, highly sensitive quantification of nucleic acids. It is used for absolute quantification and analysis of minority sequences. This type of PCR enhances the sensitivity of real-time PCR and detects rare events such as single-nucleotide mutations in a population of wild-type sequences. With digital PCR, a sample is partitioned so that individual nucleic acid molecules within the sample are localized and concentrated within many separate regions. After PCR amplification, nucleic acids may be quantified by counting the regions that contain PCR end-product and positive reactions.
The major factors that drive the growth of the digital PCR market are a rise in the prevalence of infectious disease, increase in awareness and acceptance of personalized medicines, and technological advancements in the field of digital PCR.
However, the high cost of digital PCR devices and reimbursement issues limit the market growth. However, the increase in funding for R&D activities is anticipated to provide numerous opportunities for market growth during the forecast period. Based on technology, the market is bifurcated into droplet digital PCR (ddPCR) and BEAMing digital PCR. The ddPCR segment was the major revenue contributor in2017 and is anticipated to continue this trend during the forecast period, the ddPCR technique provides a precise measure of DNA molecules through each drop. In addition, the massive sample partitioning is a key aspect of the droplet digital PCR technique, which increases the demand.
Depending on type, the market is categorized into digital PCR systems, consumables & reagents, and software & services. The software & services segment is projected to experience rapid growth during the forecast period, as the software helps to improve the efficiency of management of digital PCR data and thus, the rise in demand for these products propels the market growth.
North America was the leading revenue contributor to the global digital polymerase chain reaction market in 2017 and is expected to remain dominant throughout the forecast period. This is attributed to its well-developed healthcare industry, the presence of leading molecular diagnostics manufacturers in the region, and rise in a number of patients using personalized medicines. However, Asia-Pacific is expected to grow at the highest CAGR of 19.1% during the study period, as it offers lucrative opportunities for the molecular diagnostics players due to increasing in a number of patients suffering from chronic diseases and improvement in healthcare facilities in the region. Key Findings of the Digital PCR Market:
Based on application, the forensics segment is projected to grow at the highest rate during the analysis period. North America dominated the global digital PCR market in 2017 and is projected to continue its dominance in the future. China is expected to grow at the highest rate in Asia-Pacific during the forecast period. Based on product type, consumables and reagents was the largest contributor in 2017. Based on technology, the ddPCR segment generated the highest revenue and is expected to continue its dominance in the future.
The key players operating in the global digital PCR market include Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Expedeon AG, Fluidigm Corporation, JN Medsys, Merck KGaA, Qiagen N.V. (Formulatrix, Inc.), Stilla Technologies, Sysmex Corporation (Sysmex Inostics GmbH), and Thermo Fisher Scientific, Inc.
About Us: Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry."
CHAPTER 1: INTRODUCTION 1.1. Report description 1.2. Key benefits for stakeholders 1.3. Key market segments 1.4. Research methodology 1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools & models CHAPTER 2: EXECUTIVE SUMMARY 2.1. CXO perspective CHAPTER 3: MARKET OVERVIEW 3.1. Market definition and scope 3.2. Key findings 3.2.1. Top investment pockets 3.3. Porters five forces analysis 3.4. Top player positioning, 2017 3.5. Market dynamics 3.5.1. Drivers 3.5.1.1. Rise in prevalence of infectious diseases and cancer 3.5.1.2. Increase in awareness and acceptance of personalized medicines 3.5.1.3. Technological Advancements 3.5.2. Restraints 3.5.2.1. High cost of digital PCR devices 3.5.2.2. Reimbursement issues 3.5.3. Opportunity 3.5.3.1. Increase in funding for R&D activities CHAPTER 4: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY 4.1. Overview 4.1.1. Market size and forecast 4.2. Droplet Digital PCR 4.2.1. Key market trends, growth factors, and opportunities 4.2.2. Market size and forecast 4.2.3. Market analysis, by country 4.3. BEAMing Digital PCR 4.3.1. Key market trends, growth factors, and opportunities 4.3.2. Market size and forecast 4.3.3. Market analysis, by country CHAPTER 5: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TYPE 5.1. Overview 5.1.1. Market size and forecast 5.2. Consumables and reagents 5.2.1. Market size and forecast 5.2.2. Market analysis, by country 5.3. Digital PCR equipment 5.3.1. Market size and forecast 5.3.2. Market analysis, by country 5.4. Software & services 5.4.1. Market size and forecast 5.4.2. Market analysis, by country CHAPTER 6: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION 6.1. Overview 6.1.1. Market size and forecast 6.2. Research 6.2.1. Market size and forecast 6.2.2. Market analysis, by country 6.3. Clinical diagnostics 6.3.1. Market size and forecast 6.3.2. Market analysis, by country 6.4. Forensics 6.4.1. Market size and forecast 6.4.2. Market analysis, by country CHAPTER 7: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER 7.1. Overview 7.1.1. Market size and forecast 7.2. Clinical diagnostic laboratories 7.2.1. Market size and forecast 7.2.2. Market analysis, by country 7.3. Pharmaceuticals & biotechnology industries 7.3.1. Market size and forecast 7.3.2. Market analysis, by country 7.4. University & research organizations 7.4.1. Market size and forecast 7.4.2. Market analysis, by country CHAPTER 8: DIGITAL PCR MARKET, BY REGION 8.1. OVERVIEW 8.1.1. Market size and forecast 8.2. North America 8.2.1. Key market trends and opportunities 8.2.2. North America digital PCR market, by country 8.2.2.1. U.S. digital PCR market, by technology 8.2.2.2. U.S. digital PCR market, by type 8.2.2.3. U.S. digital PCR market, by application 8.2.2.4. U.S. digital PCR market, by end user 8.2.2.5. Canada digital PCR market, by technology 8.2.2.6. Canada digital PCR market, by type 8.2.2.7. Canada digital PCR market, by application 8.2.2.8. Canada digital PCR market, by end user 8.2.2.9. Mexico digital PCR market, by technology 8.2.2.10. Mexico digital PCR market, by type 8.2.2.11. Mexico digital PCR market, by application 8.2.2.12. Mexico digital PCR market, by end user 8.2.3. North America digital PCR market, by technology 8.2.4. North America digital PCR market, by type 8.2.5. North America digital PCR market, by application 8.2.6. North America digital PCR market, by end user 8.3. Europe 8.3.1. Key market trends and opportunities 8.3.2. Europe digital PCR market, by country 8.3.2.1. Germany digital PCR market, by technology 8.3.2.2. Germany digital PCR market, by type 8.3.2.3. Germany digital PCR market, by application 8.3.2.4. Germany digital PCR market, by end user 8.3.2.5. France digital PCR market, by technology 8.3.2.6. France digital PCR market, by type 8.3.2.7. France digital PCR market, by application 8.3.2.8. France digital PCR market, by end user 8.3.2.9. UK digital PCR market, by technology 8.3.2.10. UK digital PCR market, by type 8.3.2.11. UK digital PCR market, by application 8.3.2.12. UK digital PCR market, by end user 8.3.2.13. Italy digital PCR market, by technology 8.3.2.14. Italy digital PCR market, by type 8.3.2.15. Italy digital PCR market, by application 8.3.2.16. Italy digital PCR market, by end user 8.3.2.17. Spain digital PCR market, by technology 8.3.2.18. Spain digital PCR market, by type 8.3.2.19. Spain digital PCR market, by application 8.3.2.20. Spain digital PCR market, by end user 8.3.2.21. Rest of Europe digital PCR market, by technology 8.3.2.22. Rest of Europe digital PCR market, by type 8.3.2.23. Rest of Europe digital PCR market, by application 8.3.2.24. Rest of Europe digital PCR market, by end user 8.3.3. Europe digital PCR market, by technology 8.3.4. Europe digital PCR market, by type 8.3.5. Europe digital PCR market, by application 8.3.6. Europe digital PCR market, by end user 8.4. Asia-Pacific 8.4.1. Key market trends and opportunities 8.4.2. Asia-Pacific digital PCR market, by country 8.4.2.1. Japan digital PCR market, by technology 8.4.2.2. Japan digital PCR market, by type 8.4.2.3. Japan digital PCR market, by application 8.4.2.4. Japan digital PCR market, by end user 8.4.2.5. China digital PCR market, by technology 8.4.2.6. China digital PCR market, by type 8.4.2.7. China digital PCR market, by application 8.4.2.8. China digital PCR market, by end user 8.4.2.9. Australia digital PCR market, by technology 8.4.2.10. Australia digital PCR market, by type 8.4.2.11. Australia digital PCR market, by application 8.4.2.12. Australia digital PCR market, by end user 8.4.2.13. India digital PCR market, by technology 8.4.2.14. India digital PCR market, by type 8.4.2.15. India digital PCR market, by application 8.4.2.16. India digital PCR market, by end user 8.4.2.17. South Korea digital PCR market, by technology 8.4.2.18. South Korea digital PCR market, by type 8.4.2.19. South Korea digital PCR market, by application 8.4.2.20. South Korea digital PCR market, by end user 8.4.2.21. Taiwan digital PCR market, by technology 8.4.2.22. Taiwan digital PCR market, by type 8.4.2.23. Taiwan digital PCR market, by application 8.4.2.24. Taiwan digital PCR market, by end user 8.4.2.25. Rest of Asia-Pacific digital PCR market, by technology 8.4.2.26. Rest of Asia-Pacific digital PCR market, by type 8.4.2.27. Rest of Asia-Pacific digital PCR market, by application 8.4.2.28. Rest of Asia-Pacific digital PCR market, by end user 8.4.3. Asia-Pacific digital PCR market, by technology 8.4.4. Asia-Pacific digital PCR market, by type 8.4.5. Asia-Pacific digital PCR market, by application 8.4.6. Asia-Pacific digital PCR market, by end user 8.5. LAMEA 8.5.1. Key market trends and opportunities 8.5.2. LAMEA digital PCR market, by country 8.5.2.1. Brazil digital PCR market, by technology 8.5.2.2. Brazil digital PCR market, by type 8.5.2.3. Brazil digital PCR market, by application 8.5.2.4. Brazil digital PCR market, by end user 8.5.2.5. Saudi Arabia digital PCR market, by technology 8.5.2.6. Saudi Arabia digital PCR market, by type 8.5.2.7. Saudi Arabia digital PCR market, by application 8.5.2.8. Saudi Arabia digital PCR market, by end user 8.5.2.9. South Africa digital PCR market, by technology 8.5.2.10. South Africa digital PCR market, by type 8.5.2.11. South Africa digital PCR market, by application 8.5.2.12. South Africa digital PCR market, by end user 8.5.2.13. Rest of LAMEA digital PCR market, by technology 8.5.2.14. Rest of LAMEA digital PCR market, by type 8.5.2.15. Rest of LAMEA digital PCR market, by application 8.5.2.16. Rest of LAMEA digital PCR market, by end user 8.5.3. LAMEA digital PCR market, by technology 8.5.4. LAMEA digital PCR market, by type 8.5.5. LAMEA digital PCR market, by application 8.5.6. LAMEA digital PCR market, by end user CHAPTER 9: COMPANY PROFILES 9.1. BIO-RAD LABORATORIES, INC. (RAINDANCE TECHNOLOGIES, INC.) 9.1.1. Company overview 9.1.2. Company snapshot 9.1.3. Operating business segments 9.1.4. Business performance 9.1.5. Key strategic moves and developments 9.2. EXPEDEON AG 9.2.1. Company overview 9.2.2. Company snapshot 9.2.3. Operating business segments 9.2.4. Business performance 9.3. FLUIDIGM CORPORATION 9.3.1. Company overview 9.3.2. Company snapshot 9.3.3. Operating business segments 9.3.4. Business performance 9.4. JN MEDSYS 9.4.1. Company overview 9.4.2. Company snapshot 9.4.3. Key strategic moves and developments 9.5. MERCK KGAA 9.5.1. Company overview 9.5.2. Company snapshot 9.5.3. Operating business segments 9.5.4. Business performance 9.5.5. Key strategic moves and developments 9.6. QIAGEN N.V. (FORMULATRIX, INC.) 9.6.1. Company overview 9.6.2. Company snapshot 9.6.3. Operating business segments 9.6.4. Business performance 9.6.5. Key strategic moves and developments 9.7. STILLA TECHNOLOGIES 9.7.1. Company overview 9.7.2. Company snapshot 9.8. SYSMEX CORPORATION (SYSMEX INOSTICS GMBH) 9.8.1. Company overview 9.8.2. Company snapshot 9.8.3. Business performance 9.9. THERMO FISHER SCIENTIFIC, INC. 9.9.1. Company overview 9.9.2. Company snapshot 9.9.3. Operating business segments 9.9.4. Business performance
CHAPTER 1: INTRODUCTION
1.1. Report description 1.2. Key benefits for stakeholders 1.3. Key market segments 1.4. Research methodology
1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope 3.2. Key findings
3.2.1. Top investment pockets
3.3. Porters five forces analysis 3.4. Top player positioning, 2017 3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in prevalence of infectious diseases and cancer 3.5.1.2. Increase in awareness and acceptance of personalized medicines 3.5.1.3. Technological Advancements
3.5.2. Restraints
3.5.2.1. High cost of digital PCR devices 3.5.2.2. Reimbursement issues
3.5.3. Opportunity
3.5.3.1. Increase in funding for R&D activities
CHAPTER 4: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Droplet Digital PCR
4.2.1. Key market trends, growth factors, and opportunities 4.2.2. Market size and forecast 4.2.3. Market analysis, by country
4.3. BEAMing Digital PCR
4.3.1. Key market trends, growth factors, and opportunities 4.3.2. Market size and forecast 4.3.3. Market analysis, by country
CHAPTER 5: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Consumables and reagents
5.2.1. Market size and forecast 5.2.2. Market analysis, by country
5.3. Digital PCR equipment
5.3.1. Market size and forecast 5.3.2. Market analysis, by country
5.4. Software & services
5.4.1. Market size and forecast 5.4.2. Market analysis, by country
CHAPTER 6: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Research
6.2.1. Market size and forecast 6.2.2. Market analysis, by country
6.3. Clinical diagnostics
6.3.1. Market size and forecast 6.3.2. Market analysis, by country
6.4. Forensics
6.4.1. Market size and forecast 6.4.2. Market analysis, by country
CHAPTER 7: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Clinical diagnostic laboratories
7.2.1. Market size and forecast 7.2.2. Market analysis, by country
7.3. Pharmaceuticals & biotechnology industries
7.3.1. Market size and forecast 7.3.2. Market analysis, by country
7.4. University & research organizations
7.4.1. Market size and forecast 7.4.2. Market analysis, by country
CHAPTER 8: DIGITAL PCR MARKET, BY REGION
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends and opportunities 8.2.2. North America digital PCR market, by country
8.2.2.1. U.S. digital PCR market, by technology 8.2.2.2. U.S. digital PCR market, by type 8.2.2.3. U.S. digital PCR market, by application 8.2.2.4. U.S. digital PCR market, by end user 8.2.2.5. Canada digital PCR market, by technology 8.2.2.6. Canada digital PCR market, by type 8.2.2.7. Canada digital PCR market, by application 8.2.2.8. Canada digital PCR market, by end user 8.2.2.9. Mexico digital PCR market, by technology 8.2.2.10. Mexico digital PCR market, by type 8.2.2.11. Mexico digital PCR market, by application 8.2.2.12. Mexico digital PCR market, by end user
8.2.3. North America digital PCR market, by technology 8.2.4. North America digital PCR market, by type 8.2.5. North America digital PCR market, by application 8.2.6. North America digital PCR market, by end user
8.3. Europe
8.3.1. Key market trends and opportunities 8.3.2. Europe digital PCR market, by country
8.3.2.1. Germany digital PCR market, by technology 8.3.2.2. Germany digital PCR market, by type 8.3.2.3. Germany digital PCR market, by application 8.3.2.4. Germany digital PCR market, by end user 8.3.2.5. France digital PCR market, by technology 8.3.2.6. France digital PCR market, by type 8.3.2.7. France digital PCR market, by application 8.3.2.8. France digital PCR market, by end user 8.3.2.9. UK digital PCR market, by technology 8.3.2.10. UK digital PCR market, by type 8.3.2.11. UK digital PCR market, by application 8.3.2.12. UK digital PCR market, by end user 8.3.2.13. Italy digital PCR market, by technology 8.3.2.14. Italy digital PCR market, by type 8.3.2.15. Italy digital PCR market, by application 8.3.2.16. Italy digital PCR market, by end user 8.3.2.17. Spain digital PCR market, by technology 8.3.2.18. Spain digital PCR market, by type 8.3.2.19. Spain digital PCR market, by application 8.3.2.20. Spain digital PCR market, by end user 8.3.2.21. Rest of Europe digital PCR market, by technology 8.3.2.22. Rest of Europe digital PCR market, by type 8.3.2.23. Rest of Europe digital PCR market, by application 8.3.2.24. Rest of Europe digital PCR market, by end user
8.3.3. Europe digital PCR market, by technology 8.3.4. Europe digital PCR market, by type 8.3.5. Europe digital PCR market, by application 8.3.6. Europe digital PCR market, by end user
8.4. Asia-Pacific
8.4.1. Key market trends and opportunities 8.4.2. Asia-Pacific digital PCR market, by country
8.4.2.1. Japan digital PCR market, by technology 8.4.2.2. Japan digital PCR market, by type 8.4.2.3. Japan digital PCR market, by application 8.4.2.4. Japan digital PCR market, by end user 8.4.2.5. China digital PCR market, by technology 8.4.2.6. China digital PCR market, by type 8.4.2.7. China digital PCR market, by application 8.4.2.8. China digital PCR market, by end user 8.4.2.9. Australia digital PCR market, by technology 8.4.2.10. Australia digital PCR market, by type 8.4.2.11. Australia digital PCR market, by application 8.4.2.12. Australia digital PCR market, by end user 8.4.2.13. India digital PCR market, by technology 8.4.2.14. India digital PCR market, by type 8.4.2.15. India digital PCR market, by application 8.4.2.16. India digital PCR market, by end user 8.4.2.17. South Korea digital PCR market, by technology 8.4.2.18. South Korea digital PCR market, by type 8.4.2.19. South Korea digital PCR market, by application 8.4.2.20. South Korea digital PCR market, by end user 8.4.2.21. Taiwan digital PCR market, by technology 8.4.2.22. Taiwan digital PCR market, by type 8.4.2.23. Taiwan digital PCR market, by application 8.4.2.24. Taiwan digital PCR market, by end user 8.4.2.25. Rest of Asia-Pacific digital PCR market, by technology 8.4.2.26. Rest of Asia-Pacific digital PCR market, by type 8.4.2.27. Rest of Asia-Pacific digital PCR market, by application 8.4.2.28. Rest of Asia-Pacific digital PCR market, by end user
8.4.3. Asia-Pacific digital PCR market, by technology 8.4.4. Asia-Pacific digital PCR market, by type 8.4.5. Asia-Pacific digital PCR market, by application 8.4.6. Asia-Pacific digital PCR market, by end user
8.5. LAMEA
8.5.1. Key market trends and opportunities 8.5.2. LAMEA digital PCR market, by country
8.5.2.1. Brazil digital PCR market, by technology 8.5.2.2. Brazil digital PCR market, by type 8.5.2.3. Brazil digital PCR market, by application 8.5.2.4. Brazil digital PCR market, by end user 8.5.2.5. Saudi Arabia digital PCR market, by technology 8.5.2.6. Saudi Arabia digital PCR market, by type 8.5.2.7. Saudi Arabia digital PCR market, by application 8.5.2.8. Saudi Arabia digital PCR market, by end user 8.5.2.9. South Africa digital PCR market, by technology 8.5.2.10. South Africa digital PCR market, by type 8.5.2.11. South Africa digital PCR market, by application 8.5.2.12. South Africa digital PCR market, by end user 8.5.2.13. Rest of LAMEA digital PCR market, by technology 8.5.2.14. Rest of LAMEA digital PCR market, by type 8.5.2.15. Rest of LAMEA digital PCR market, by application 8.5.2.16. Rest of LAMEA digital PCR market, by end user
8.5.3. LAMEA digital PCR market, by technology 8.5.4. LAMEA digital PCR market, by type 8.5.5. LAMEA digital PCR market, by application 8.5.6. LAMEA digital PCR market, by end user
CHAPTER 9: COMPANY PROFILES
9.1. BIO-RAD LABORATORIES, INC. (RAINDANCE TECHNOLOGIES, INC.)
9.1.1. Company overview 9.1.2. Company snapshot 9.1.3. Operating business segments 9.1.4. Business performance 9.1.5. Key strategic moves and developments
9.2. EXPEDEON AG
9.2.1. Company overview 9.2.2. Company snapshot 9.2.3. Operating business segments 9.2.4. Business performance
9.3. FLUIDIGM CORPORATION
9.3.1. Company overview 9.3.2. Company snapshot 9.3.3. Operating business segments 9.3.4. Business performance
9.4. JN MEDSYS
9.4.1. Company overview 9.4.2. Company snapshot 9.4.3. Key strategic moves and developments
9.5. MERCK KGAA
9.5.1. Company overview 9.5.2. Company snapshot 9.5.3. Operating business segments 9.5.4. Business performance 9.5.5. Key strategic moves and developments
9.6. QIAGEN N.V. (FORMULATRIX, INC.)
9.6.1. Company overview 9.6.2. Company snapshot 9.6.3. Operating business segments 9.6.4. Business performance 9.6.5. Key strategic moves and developments
9.7. STILLA TECHNOLOGIES
9.7.1. Company overview 9.7.2. Company snapshot
9.8. SYSMEX CORPORATION (SYSMEX INOSTICS GMBH)
9.8.1. Company overview 9.8.2. Company snapshot 9.8.3. Business performance
9.9. THERMO FISHER SCIENTIFIC, INC.
9.9.1. Company overview 9.9.2. Company snapshot 9.9.3. Operating business segments 9.9.4. Business performance
TABLE 01. GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 02. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR DROPLET DIGITAL PCR, BY REGION, 20172025 ($MILLION) TABLE 03. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR BEAMING DIGITAL PCR, BY REGION, 20172025 ($MILLION) TABLE 04. GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 05. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES AND REAGENTS, BY REGION, 20172025 ($MILLION) TABLE 06. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR DIGITAL PCR SYSTEMS, BY REGION, 20172025 ($MILLION) TABLE 07. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICES, BY REGION, 20172025 ($MILLION) TABLE 08. GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 09. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH, BY REGION, 20172025 ($MILLION) TABLE 10. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 20172025 ($MILLION) TABLE 11. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC, BY REGION, 20172025 ($MILLION) TABLE 12. GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER, 20172025 ($MILLION) TABLE 13. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 20172025 ($MILLION) TABLE 14. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY REGION, 20172025 ($MILLION) TABLE 15. DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITY & GOVERNMENT ORGANIZATIONS, BY REGION, 20172025 ($MILLION) TABLE 16. DIGITAL PCR MARKET REVENUE, BY REGION, 20172025 ($MILLION) TABLE 17. NORTH AMERICA DIGITAL PCR MARKET, BY COUNTRY, 20172025 ($MILLION) TABLE 18. U.S. DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 19. U.S. DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 20. U.S. DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 21. U.S. DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 22. CANADA DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 23. CANADA DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 24. CANADA DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 25. CANADA DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 26. MEXICO DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 27. MEXICO DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 28. MEXICO DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 29. MEXICO DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 30. NORTH AMERICA DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 31. NORTH AMERICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 32. NORTH AMERICA DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 33. NORTH AMERICA DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 34. EUROPE DIGITAL PCR MARKET, BY COUNTRY, 20172025 ($MILLION) TABLE 35. GERMANY DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 36. GERMANY DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 37. GERMANY DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 38. GERMANY DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 39. FRANCE DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 40. FRANCE DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 41. FRANCE DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 42. FRANCE DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 43. UK DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 44. UK DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 45. UK DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 46. UK DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 47. ITALY DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 48. ITALY DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 49. ITALY DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 50. ITALY DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 51. SPAIN DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 52. SPAIN DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 53. SPAIN DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 54. SPAIN DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 55. REST OF EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 56. REST OF EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 57. REST OF EUROPE DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 58. REST OF EUROPE DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 59. EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 60. EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 61. EUROPE DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 62. EUROPE DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 63. ASIA-PACIFIC DIGITAL PCR MARKET, BY COUNTRY, 20172025 ($MILLION) TABLE 64. JAPAN DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 65. JAPAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 66. JAPAN DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 67. JAPAN DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 68. CHINA DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 69. CHINA DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 70. CHINA DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 71. CHINA DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 72. AUSTRALIA DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 73. AUSTRALIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 74. AUSTRALIA DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 75. AUSTRALIA DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 76. INDIA DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 77. INDIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 78. INDIA DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 79. INDIA DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 80. SOUTH KOREA DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 81. SOUTH KOREA DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 82. SOUTH KOREA DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 83. SOUTH KOREA DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 84. TAIWAN DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 85. TAIWAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 86. TAIWAN DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 87. TAIWAN DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 88. REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 89. REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 90. REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 91. REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 92. ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 93. ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 94. ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 95. ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 96. LAMEA DIGITAL PCR MARKET, BY COUNTRY, 20172025 ($MILLION) TABLE 97. BRAZIL DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 98. BRAZIL DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 99. BRAZIL DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 100. BRAZIL DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 101. SAUDI ARABIA DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 102. SAUDI ARABIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 103. SAUDI ARABIA DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 104. SAUDI ARABIA DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 105. SOUTH AFRICA DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 106. SOUTH AFRICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 107. SOUTH AFRICA DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 108. SOUTH AFRICA DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 109. REST OF LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 110. REST OF LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 111. REST OF LAMEA DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 112. REST OF LAMEA DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 113. LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 20172025 ($MILLION) TABLE 114. LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 20172025 ($MILLION) TABLE 115. LAMEA DIGITAL PCR MARKET, BY APPLICATION, 20172025 ($MILLION) TABLE 116. LAMEA DIGITAL PCR MARKET, BY END USER, 20172025 ($MILLION) TABLE 117. BIO-RAD: COMPANY SNAPSHOT TABLE 118. BIO-RAD: OPERATING SEGMENTS TABLE 119. EXPEDEON: COMPANY SNAPSHOT TABLE 120. FLUIDIGM: COMPANY SNAPSHOT TABLE 121. JN MEDSYS: COMPANY SNAPSHOT TABLE 122. MERCK: COMPANY SNAPSHOT TABLE 123. MERCK: OPERATING SEGMENTS TABLE 124. QIAGEN: COMPANY SNAPSHOT TABLE 125. STILLA TECHNOLOGIES: COMPANY SNAPSHOT TABLE 126. SYSMEX: COMPANY SNAPSHOT TABLE 127. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT TABLE 128. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
FIGURE 01. SEGMENTATION OF DIGITAL POLYMERASE CHAIN REACTION MARKET FIGURE 02. TOP INVESTMENT POCKETS, 2017 FIGURE 03. LOW BARGAINING POWER OF SUPPLIERS FIGURE 04. MODERATE BARGAINING POWER OF BUYERS FIGURE 05. HIGH THREAT OF SUBSTITUTION FIGURE 06. LOW THREAT OF NEW ENTRANT FIGURE 07. MODERATE COMPETITIVE RIVALRY FIGURE 08. GLOBAL DIGITAL POLYMERASE CHAIN REACTION TOP PLAYER POSITIONING, 2017 FIGURE 09. GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES FIGURE 10. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR DROPLET DIGITAL PCR, BY COUNTRY, 2017 & 2025 (%) FIGURE 11. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR BEAMING DIGITAL PCR, BY COUNTRY, 2017 & 2025 (%) FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES AND REAGENTS, BY COUNTRY, 2017 & 2025 (%) FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR DIGITAL PCR EQUIPMENT, BY COUNTRY, 2017 & 2025 (%) FIGURE 14. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICE, BY COUNTRY, 2017 & 2025 (%) FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH, BY COUNTRY, 2017 & 2025 (%) FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017 & 2025 (%) FIGURE 17. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC, BY COUNTRY, 2017 & 2025 (%) FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017 & 2025 (%) FIGURE 19. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY COUNTRY, 2017 & 2025 (%) FIGURE 20. COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITY & GOVERNMENT ORGANIZATIONS, BY COUNTRY, 2017 & 2025 (%) FIGURE 21. BIO-RAD: NET SALES, 20152017 ($MILLION) FIGURE 22. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%) FIGURE 23. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%) FIGURE 24. EXPEDEON: NET SALES, 20152017 ($MILLION) FIGURE 25. EXPEDEON: REVENUE SHARE BY REGION, 2017 (%) FIGURE 26. FLUIDIGM: NET SALES, 20152017 ($MILLION) FIGURE 27. FLUIDIGM: REVENUE SHARE BY GEOGRAPHY, 2017 (%) FIGURE 28. MERCK: NET SALES, 20152017 ($MILLION) FIGURE 29. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%) FIGURE 30. MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%) FIGURE 31. QIAGEN: REVENUE SHARE BY PRODUCT, 2017 (%) FIGURE 32. QIAGEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%) FIGURE 33. SYSMEX: NET SALES, 20162018 ($MILLION) FIGURE 34. SYSMEX: REVENUE SHARE BY PRODUCT & SERVICES, 2018 (%) FIGURE 35. SYSMEX: REVENUE SHARE BY REGION, 2018 (%) FIGURE 36. THERMO FISHER SCIENTIFIC: REVENUE, 20152017 ($MILLION) FIGURE 37. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2017 (%) FIGURE 38. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
UK : +44 141 628 9353 US : +1 970 279 4295
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics